Improve your understanding of the cardiopulmonary system with Essentials of Cardiopulmonary Physical Therapy, 5th Edition. Based on American Physical Therapy Association best practices, this new edition provides comprehensive coverage of anatomy, physiology, and cardiopulmonary assessment, along with new chapters on the growing topics of the management of cardiovascular disease in women and pulmonary vascular disease. Using a practical approach, expert author Ellen Hillegass also discusses pathophysiology, pharmacology, and interventions in the outpatient setting.
1. Introduction - p. 259 2. Obesity - p. 259 3. Diabetes mellitus - p. 271 4. Clinical implications for physical therapy - p. 277 5. Chronic kidney disease and failure - p. 281 6. Other specific diseases and disorders - p. 286 7. Cardiopulmonary toxicity of cancer treatment - p. 295 8. Summary - p. 298 9. Section 3. Diagnostic Tests and Procedures - p. 307 10. 10. Cardiovascular diagnostic tests and procedures - p. 307 11. Diagnostic test interpretation and probability of disease - p. 309 12. Sensitivity/specificity of testing - p. 309 13. Clinical laboratory studies - p. 309 14. Other noninvasive diagnostic tests - p. 317 15. Other imaging modalities - p. 320 16. Exercise testing - p. 321 17. Pharmacologic stress testing - p. 330 18. Cardiac catheterization: coronary angiography and ventriculography - p. 334 19. Digital subtraction angiography - p. 336 20. Endocardial biopsy - p. 337 21. Vascular diagnostic testing for aortic, peripheral, and carotid disease - p. 337 22. Peripheral arterial disease and dysfunction and diagnosis - p. 337 23. Carotid artery disease and diagnosis - p. 341 24. Summary - p. 342 25. 11. Electrocardiography - p. 347 26. 12. Pulmonary diagnostic tests and procedures - p. 380.e1 27. Section 4. Surgical Interventions, Monitoring, and Support - p. 407 28. 13. Cardiovascular and thoracic interventions - p. 407 29. 14. Thoracic organ transplantation heart and lung - p. 435.e1 30. 15. Monitoring, life support devices, and respiratory care in intensive care unit - p. 468 31. Monitoring equipment in the intensive care unit - p. 468 32. Capnography - p. 471 33. Invasive monitoring - p. 475 34. Temperature monitoring - p. 481 35. Intracranial pressure monitoring - p. 482 36. Life support equipment - p. 482 37. Summary - p. 509 38. Section 5. Pharmacology - p. 513 39. 16. Cardiovascular medications - p. 513 40. Pharmacokinetics - p. 515 41. Pharmacodynamics - p. 517 42. General considerations of pharmacologic management - p. 518 43. Cardiac drugs used in critical care - p. 547 44. Cardiac pharmacology in the geriatric population - p. 551 45. Cardiac pharmacology in the neonate and pediatric populations - p. 552 46. Pharmacologic management of diabetes - p. 553 47. Heart transplantation - p. 556 48. Vascular pharmacology - p. 558 49. Summary - p. 560 50. 17. Pulmonary medications - p. 564.e1 51. Section 6. Cardiopulmonary Assessment and Intervention - p. 585.e1 52. 18. Examination and assessment procedures - p. 585.e1 53. 19. Interventions for acute cardiopulmonary conditions - p. 620.e1 54. 20. Interventions and prevention measures for individuals with cardiovascular disease, or risk of disease - p. 654.e1 55. Introduction - p. 654.e1 56. Primary prevention - p. 656 57. Rehabilitation of patients with documented cardiovascular disease - p. 658 58. Management and evaluation of patients during the acute phase - p. 660 59. Postacute phase rehabilitation - p. 667 60. Candidacy - p. 667 61. Home-based cardiac rehabilitation - p. 667 62. Rehabilitation/secondary prevention in the outpatient setting - p. 668 63. Secondary prevention: management of risk factors - p. 678 64. Administrative considerations - p. 689 65. Summary - p. 693 66. 21. Pulmonary rehabilitation - p. 696.e4 67. 22. Pediatric cardiopulmonary physical therapy - p. 721 68. 23. Outcome measures: A guide for the evidence-based practice of cardiopulmonary physical therapy - p. 747 69. 24. The lymphatic system - p. 778 70. Glossary - p. 804.e1 71. Index - p. e35
Improve your understanding of the cardiopulmonary system with Essentials of Cardiopulmonary Physical Therapy, 5th Edition. Based on American Physical Therapy Association best practices, this new edition provides comprehensive coverage of anatomy, physiology, and cardiopulmonary assessment, along with new chapters on the growing topics of the management of cardiovascular disease in women and pulmonary vascular disease. Using a practical approach, expert author Ellen Hillegass also discusses pathophysiology, pharmacology, and interventions in the outpatient setting.
1. Introduction - p. 259 2. Obesity - p. 259 3. Diabetes mellitus - p. 271 4. Clinical implications for physical therapy - p. 277 5. Chronic kidney disease and failure - p. 281 6. Other specific diseases and disorders - p. 286 7. Cardiopulmonary toxicity of cancer treatment - p. 295 8. Summary - p. 298 9. Section 3. Diagnostic Tests and Procedures - p. 307 10. 10. Cardiovascular diagnostic tests and procedures - p. 307 11. Diagnostic test interpretation and probability of disease - p. 309 12. Sensitivity/specificity of testing - p. 309 13. Clinical laboratory studies - p. 309 14. Other noninvasive diagnostic tests - p. 317 15. Other imaging modalities - p. 320 16. Exercise testing - p. 321 17. Pharmacologic stress testing - p. 330 18. Cardiac catheterization: coronary angiography and ventriculography - p. 334 19. Digital subtraction angiography - p. 336 20. Endocardial biopsy - p. 337 21. Vascular diagnostic testing for aortic, peripheral, and carotid disease - p. 337 22. Peripheral arterial disease and dysfunction and diagnosis - p. 337 23. Carotid artery disease and diagnosis - p. 341 24. Summary - p. 342 25. 11. Electrocardiography - p. 347 26. 12. Pulmonary diagnostic tests and procedures - p. 380.e1 27. Section 4. Surgical Interventions, Monitoring, and Support - p. 407 28. 13. Cardiovascular and thoracic interventions - p. 407 29. 14. Thoracic organ transplantation heart and lung - p. 435.e1 30. 15. Monitoring, life support devices, and respiratory care in intensive care unit - p. 468 31. Monitoring equipment in the intensive care unit - p. 468 32. Capnography - p. 471 33. Invasive monitoring - p. 475 34. Temperature monitoring - p. 481 35. Intracranial pressure monitoring - p. 482 36. Life support equipment - p. 482 37. Summary - p. 509 38. Section 5. Pharmacology - p. 513 39. 16. Cardiovascular medications - p. 513 40. Pharmacokinetics - p. 515 41. Pharmacodynamics - p. 517 42. General considerations of pharmacologic management - p. 518 43. Cardiac drugs used in critical care - p. 547 44. Cardiac pharmacology in the geriatric population - p. 551 45. Cardiac pharmacology in the neonate and pediatric populations - p. 552 46. Pharmacologic management of diabetes - p. 553 47. Heart transplantation - p. 556 48. Vascular pharmacology - p. 558 49. Summary - p. 560 50. 17. Pulmonary medications - p. 564.e1 51. Section 6. Cardiopulmonary Assessment and Intervention - p. 585.e1 52. 18. Examination and assessment procedures - p. 585.e1 53. 19. Interventions for acute cardiopulmonary conditions - p. 620.e1 54. 20. Interventions and prevention measures for individuals with cardiovascular disease, or risk of disease - p. 654.e1 55. Introduction - p. 654.e1 56. Primary prevention - p. 656 57. Rehabilitation of patients with documented cardiovascular disease - p. 658 58. Management and evaluation of patients during the acute phase - p. 660 59. Postacute phase rehabilitation - p. 667 60. Candidacy - p. 667 61. Home-based cardiac rehabilitation - p. 667 62. Rehabilitation/secondary prevention in the outpatient setting - p. 668 63. Secondary prevention: management of risk factors - p. 678 64. Administrative considerations - p. 689 65. Summary - p. 693 66. 21. Pulmonary rehabilitation - p. 696.e4 67. 22. Pediatric cardiopulmonary physical therapy - p. 721 68. 23. Outcome measures: A guide for the evidence-based practice of cardiopulmonary physical therapy - p. 747 69. 24. The lymphatic system - p. 778 70. Glossary - p. 804.e1 71. Index - p. e35
